Table 1.
Baseline characteristics of hemodialysis (HD) patients with and without obesity
Variable | Non-obese | Obese | P value |
---|---|---|---|
Subject | 567 (77.4) | 166 (22.6) | |
Age (yr) | 52 ± 13.4 | 56 ± 10.7 | 0.155* |
Duration of HD (mo) | 60 (16–228) | 56 (18–204) | 0.568† |
Sex | |||
Female | 204 (36.0) | 84 (50.6) | 0.001‡ |
Male | 363 (64.0) | 82 (49.4 ) | |
Diabetes mellitus | |||
No | 440 (77.6) | 127 (76.5) | 0.935‡ |
Yes | 127 (22.4) | 39 (23.5) | |
Hypertension | |||
No | 298 (52.6) | 79 (47.6) | 0.357‡ |
Yes | 269 (47.4) | 87 (52.4) | |
Serum creatinine (mg/dL) | 7.2 (2–17) | 7.6 (3–14.8) | 0.275† |
URR (%) | 58 (25–87) | 60 (27–82) | 0.251† |
Serum albumin (g/dL) | 4 ± 0.64 | 4.2 ± 0.47 | 0.279* |
Serum Ca (mg/dL) | 9.3 ± 1.5 | 9.0 ± 1.3 | 0.492* |
Serum phosphorus (mg/dL) | 4.8 (2.0–9.3) | 5.4 (2.8–10.5) | 0.005† |
iPTH (pg/mL) | 299.0 (4.7–3,576.0) | 281.0 (16.0–1,654.0) | 0.888† |
Data are presented as number (%), mean ± standard deviation, or median (range).
iPTH, intact parathyroid hormone; URR, urea reduction ratio.
Analyzed by
Student t test,
Mann–Whitney U test,
chi-square test.